Federal Judge Terminates Motion to Amend Judgment…in Cursive

  • September 21, 2020
  • Category: Biotech and Pharma, In Case You Missed It

Last week, Chief Judge Colleen McMahon of the Southern District of New York made clear that she is through “making findings” in a declaratory judgment action brought by Ferring Pharmaceuticals against Reprise Pharmaceutics and Serenity Pharmaceuticals over the drug desmopressin, taking the unusual step of handwriting on the face of a brief her reasons for terminating a motion to amend the judgment to prepare it for appeal to the Federal Circuit: “I refuse to ‘pretend’ that there is a valid patent to infringe and make findings as though there were one. In fact, I am DONE making findings”.


View full article with free 30-day trial
($79/month thereafter)


  • Over 7,000 news articles covering new patent cases, key policy decisions, and USPTO assignments
  • Advanced custom alerts for campaigns and entities
  • Proprietary litigation timelines
  • Full access to Federal Circuit, PTAB, and ITC dockets
  • Judge, venue, and law firm analytics



×
×

Thank you for your feedback

×
×